Views: 28
Just Putting this out there. Vaccines and Long COVID. Below are portions about the threat of Long COVID especially for the folks who are into getting the JAB. One of the links below also show how a popular drug for COVID has reverse results in some folks.
Paxlovid May Not Be Associated With Lower Long COVID Risk, Survey Suggests
One in five of treated with the agent reported rebound COVID symptoms, researchers found.
Nirmatrelvir-ritonavir (Paxlovid) did not reduce the odds of developing long COVID in vaccinated, non-hospitalized adults, survey data showed.
About 16% of those treated with nirmatrelvir-ritonavir during acute infection with SARS-CoV-2 self-reported long COVID symptoms that persisted for 3 months or longer after infection, compared with 14% of those who were not treated with the medication (P=0.310), noted Matthew Durstenfeld, MD, of Zuckerberg San Francisco General Hospital, and colleagues in the Journal of Medical Virologyopens in a new tab or window.
The survey data also showed a high rate of rebound among participants who took nirmatrelvir-ritonavir. About 21% of participants who had symptomatic improvement with the agent went on to report rebound symptoms. Also, nearly 26% of patients who completed treatment and tested negative for SARS-CoV-2 reported a subsequent positive antigen test, indicating rebound.
97
